Relmada Therapeutics Inc’s recently made public that its Chief Financial Officer Shenouda Maged acquired Company’s shares for reported $1.1 million on Nov 05 ’25. In the deal valued at $2.20 per share,500,000 shares were bought. As a result of this transaction, Shenouda Maged now holds 788,335 shares worth roughly $3.37 million.
Then, Ence Chuck bought 136,000 shares, generating $299,200 in total proceeds. Upon buying the shares at $2.20, the CAO and COO now owns 403,931 shares.
Before that, TRAVERSA SERGIO bought 272,500 shares. Relmada Therapeutics Inc shares valued at $599,500 were divested by the Chief Executive Officer at a price of $2.20 per share. As a result of the transaction, TRAVERSA SERGIO now holds 1,272,500 shares, worth roughly $5.43 million.
Mizuho upgraded its Relmada Therapeutics Inc [RLMD] rating to an Outperform from a a Neutral in a research note published recently A number of analysts have revised their coverage, including Mizuho’s analysts, who decreased its forecast for the stock in early December from “an Outperform” to “a Neutral”. Jefferies also remained covering RLMD and has increased its forecast on September 17, 2024 with a “Buy” recommendation from previously “Hold” rating. Goldman revised its rating on June 05, 2024. It rated RLMD as “a Sell” which previously was an “a Neutral”.
Price Performance Review of RLMD
On Friday, Relmada Therapeutics Inc [NASDAQ:RLMD] saw its stock fall -1.16% to $4.27. Over the last five days, the stock has gained 8.10%. Relmada Therapeutics Inc shares have risen nearly 43.29% since the year began. Nevertheless, the stocks have risen 721.15% over the past one year. While a 52-week high of $5.12 was reached on 11/19/25, a 52-week low of $0.24 was recorded on 03/03/25.
Levels Of Support And Resistance For RLMD Stock
The 24-hour chart illustrates a support level at 3.93, which if violated will result in even more drops to 3.59. On the upside, there is a resistance level at 4.49. A further resistance level may holdings at 4.71.
How much short interest is there in Relmada Therapeutics Inc?
A steep rise in short interest was recorded in Relmada Therapeutics Inc stocks on 2025-10-31, dropping by -0.32 million shares to a total of 0.51 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 0.84 million shares. There was a decline of -62.55%, which implies that there is a negative sentiment for the stock.
